Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04305015 · ClinicalTrials.gov registry record · NA

Postoperative Benefits of Intraoperative Nociception Level (NOL) Titration - Pilot

A NA study of Nociceptive Pain, sponsored by Medasense Biometrics.

Completed
Registry status
NA
Development phase
26
Enrollment target
1
Study location

NCT04305015 is a NA study of Nociceptive Pain that has completed, run by Medasense Biometrics. The registered enrollment target is 26 participants, below the 218-participant average among 3 other Nociceptive Pain trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04305015, a NA study of Nociceptive Pain, has completed, sponsored by Medasense Biometrics.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target
1
Study location

Study Summary

Previous work has shown that NOL (Medasense, Ramat Gan, Israel) accurately quantifies nociception during general anesthesia. Presumably, titrating opioids to NOL will therefore provide individual guidance so that patients will be given about the right amount. Patient given the right amount will presumably awaken quickly when anesthesia is done, and have good initial pain control in the post anesthesia care unit (PACU). To the extent that NOL titration facilitates optimal opioid dosing, patients are likely to have better PACU experiences - which would be an important outcome that clinicians and regulators are likely to take seriously.

Conditions Studied

Interventions

  • DEVICE NOL Guided Analgesia
  • OTHER Routine opioid management

Study Locations (1)

Ohio

  • Cleveland clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2020-11-09
Est. Completion 2020-12-30
Phase NA

Sponsor

Medasense Biometrics

2 total trials

What the Registry Record Tells You About NCT04305015

The ClinicalTrials.gov registry entry for NCT04305015 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 218-participant average among 3 other Nociceptive Pain trials with a reported enrollment target (88% lower). The listed sponsor is Medasense Biometrics, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Nociceptive Pain appearing as the primary indexed condition, and to 2 interventions - of which NOL Guided Analgesia is the first listed.

NCT04305015 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT04305015 about?

NCT04305015 is a clinical study titled "Postoperative Benefits of Intraoperative Nociception Level (NOL) Titration - Pilot". Previous work has shown that NOL (Medasense, Ramat Gan, Israel) accurately quantifies nociception during general anesthesia. Presumably, titrating opioids to NOL will therefore provide individual guidance so that patients will be given about the right amount. Patient given the right amount will pres...

What is the current status of trial NCT04305015?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2020-11-09. Estimated completion is 2020-12-30.

What conditions does trial NCT04305015 study?

This clinical trial studies the following conditions: Nociceptive Pain.

What interventions are being tested in trial NCT04305015?

The interventions under investigation include: NOL Guided Analgesia (DEVICE), Routine opioid management (OTHER).

Who is sponsoring clinical trial NCT04305015?

This trial is sponsored by Medasense Biometrics, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04305015 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nociceptive Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.